$16.96 -0.26 (-1.51%)
2/10/2012 4:00 PM

Incyte Corp (NASDAQ:INCY)

CAPS Rating: 2 out of 5

The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.

Featured Broker Partners


Advertisement